Acquiring nerve activity from carotid body and/or sinus

• US 7,949,398 B1
• Filed: 12/27/2007
• Issued: 05/24/2011
• Est. Priority Date: 12/27/2007
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Wenzel, Brian Jeffrey, Farazi, Taraneh Ghaffari
• Primary Examiner(s): Patel; Niketa I
• Assistant Examiner(s): EL-KAISSI, HIBA CARINE
• Application Number:
  US11/964,941
• Time in Patent Office: 1,244 Days
• Field of Search: 607/9, 607/17, 607/32, 607/42, 607/44, 607/59, 607/117, 607/118
• US Class Current: 607/42
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/4047 afferent nerves, i.e. nerves that relay impulses to the central nervous system
• CPC Class Codes: A61B 5/4818 Sleep apnoea
• CPC Class Codes: A61B 5/4866 Evaluating metabolism A61B5/083 takes precedence
• CPC Class Codes: A61B 5/7264 Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems neural networks per se G06N3/00; expert systems per se G06N5/00
• CPC Class Codes: A61N 1/36117 for treating hypertension
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/3702 Physiological parameters A61N1/365 takes precedence; evoked response A61N1/371

Abstract

An exemplary includes acquiring an electroneurogram of the right carotid sinus nerve or the left carotid sinus nerve, analyzing the electroneurogram for at least one of chemosensory information and barosensory information and calling for one or more therapeutic actions based at least in part on the analyzing. Therapeutic actions may aim to treat conditions such as sleep apnea, an increase in metabolic demand, hypoglycemia, hypertension, renal failure, and congestive heart failure. Other exemplary methods, devices, systems, etc., are also disclosed.

Claims

1. A system comprising:

an implantable device that comprises;

a processor, a memory, a telemetry circuit, a lead bearing one or more electrodes configured to sense electrical activity of the right carotid sinus nerve or the left carotid sinus nerve, and control logic, configured in conjunction with the processor, to store in the memory the sensed electrical activity or information derived from processing the sensed electrical activity by the processor; and

an external, positive airway pressure device that comprises;

a processor, a memory, a telemetry circuit, and control logic configured to download, via the telemetry circuit of the external device, the sensed electrical activity or the information derived from the sensed electrical activity from the memory of the implantable device, wherein the control logic of the external device is configured in conjunction with the processor of the external device, to;

store in the memory of the external device one or more relationships between carotid sinus nerve activity and at least one member of the group consisting of ventilation rate, blood carbon dioxide concentration, blood oxygen concentration and blood pH;

determine at least one member of the group consisting of ventilation rate, blood carbon dioxide concentration, blood oxygen concentration and blood pH downloaded based on the sensed electrical activity and the one or more relationships; and

determine if sleep apnea exists based at least in part on chemosensory discharges of a carotid body per the at least one determined member.

2. The system of claim 1 wherein the external device comprises control logic configured to program one or more operational parameters of the implantable device.

3. The system of claim 1 wherein the control logic of the external device is configured to make a diagnosis based at least in part on blood CO₂ chemosensory discharges of a carotid body.

4. The system of claim 1 wherein the control logic of the external device is configured to make a diagnosis based at least in part on blood O₂ chemosensory discharges of a carotid body.

5. The system of claim 1 wherein the control logic of the external device is configured to make a diagnosis based at least in part on blood pH chemosensory discharges of a carotid body.

6. A system comprising:

an implantable device that comprises;

a processor, a memory, a telemetry circuit, a lead bearing one or more electrodes configured to sense electrical activity of the right carotid sinus nerve or the left carotid sinus nerve, and control logic, configured in conjunction with the processor, to store in the memory sensed electrical activity or information derived from processing the sensed electrical activity by the processor; and

an external glucometer that comprises;

a processor, a memory, a telemetry circuit, control logic configured to download, via the telemetry circuit, the sensed electrical activity or the information derived from the sensed electrical activity from the memory of the implantable device, wherein the control logic of the external glucometer is configured in conjunction with the processor of the external device, to store a relationship between chemosensory discharges of a carotid body and blood glucose concentration in the memory of the external glucometer and wherein the control logic of the external glucometer is further configured to make a diagnosis based at least in part on chemosensory discharges of a carotid body per the downloaded sensed electrical activity or the downloaded information derived from the sensed electrical activity and the stored relationship.

7. The system of claim 6 wherein the control logic of the external glucometer is configured to make a diagnosis based at least in part on chemosensory discharges of a carotid body responsive to a metabolic poison.

8. The system of claim 6 wherein the control logic of the external glucometer is configured to make a diagnosis based at least in part on chemosensory discharges of a carotid body responsive to a metabolic poison.

9. The system of claim 8 wherein the drug comprises insulin.

10. A system comprising:

an implantable device that comprises;

a processor, a memory, a telemetry circuit, a lead bearing one or more electrodes configured to sense electrical activity of the right carotid sinus nerve or the left carotid sinus nerve, and control logic, configured in conjunction with the processor, to;

store in the memory of the implantable device one or more relationships between carotid sinus nerve activity and at least one member of the group consisting of ventilation rate, blood carbon dioxide concentration, blood oxygen concentration and blood pH;

determine at least one member of the group consisting of ventilation rate, blood carbon dioxide concentration, blood oxygen concentration and blood pH downloaded based on the sensed electrical activity and the one or more relationships; and

store in the memory of the implantable device the at least one member; and

an external, positive airway pressure device that comprises;

a processor, a memory, a telemetry circuit, and control logic configured to download, via the telemetry circuit of the external device, the at least one member, wherein the control logic of the external device is configured in conjunction with the processor of the external device, to determine if sleep apnea exists based at least in part on chemosensory discharges of a carotid body per the at least one member.